Deals
Thermo Fisher Extends Buying Binge With Talks to Acquire Patheon
- Deal agreement could be reached as early as this week
- CEO Marc Casper has been expanding Thermo Fisher through M&A
Thermo Fischer to Buy Patheon in $7.2 Billion Deal
This article is for subscribers only.
Thermo Fisher Scientific Inc., which became one of the world’s biggest manufacturers of diagnostic and testing equipment through acquisitions, has its sights on another deal.
The U.S. company is in talks to buy Patheon NV, a maker of drug ingredients that began trading less than a year ago, according to people with knowledge of the matter. An agreement could be reached as early as this week, the people said, asking not to be identified because the information is private.